# Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy

> **NCT02169336** · PHASE2 · TERMINATED · sponsor: **Baudax Bio** · enrollment: 95 (actual)

## Conditions studied

- Pain, Post-operative

## Interventions

- **DRUG:** Intranasal Dexmedetomidine
- **OTHER:** Intranasal Placebo

## Key facts

- **NCT ID:** NCT02169336
- **Lead sponsor:** Baudax Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 95 (ACTUAL)
- **Why stopped:** Lack of observed efficacy
- **Last updated:** 2015-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02169336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02169336, "Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02169336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*